Healthcare
Live Price
Offline$0.61
+0.00% today
1Y Change
-94.93%
Window
Jun 23, 2025 β Jun 15, 2026
Coverage: 247 bars Β· Jun 23, 2025 β Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Reviva Pharmaceuticals Holdings, Inc. (RVPH) is a Healthcare stock with listed on NASDAQ. The stock last traded around $0.61 and down 94.9% across the available one-year price window (Jun 23, 2025 β Jun 15, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +69.6%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +69.6%, free cash flow -73320626.8% with operating margin 0.0% and ROIC -223.1%. Stock Foundry combines RVPH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RVPH
β
Normalized return
SPY
β
S&P 500
Excess Return
β
Relative to SPY
RVPH Max Drawdown
-98.02%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Uses the longest available daily history for RVPH and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$8.5M
+65.0% YoY
Free Cash Flow
-$10.7M
+43.7% YoY
Revenue Growth
+0.0%
EPS Growth
+69.6%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -20200.0B | -31M | -40M | -24M | -10M |
| EBITDA | -20200.0B | -30M | -39M | -24M | -10M |
| Net Income | -19864.9B | -30M | -39M | -24M | -9M |
| EPS (Diluted) | β | β | β | β | β |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 14438.8B | 13M | 23M | 19M | 30M |
| Total Assets | 15923.2B | 16M | 24M | 19M | 31M |
| Total Liabilities | 7275.6B | 15M | 18M | 11M | 3M |
| Shareholder Equity | 8647.6B | 813K | 6M | 8M | 29M |
| Total Debt | 406.9B | 458K | 0 | 0 | 0 |
| Net Debt | -14031.9B | -13M | -23M | -19M | -30M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
11M
+43.7% YoY
Capital Expenditures
0
Free Cash Flow
11M
+43.7% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-918.9%
Debt / Equity
0.05x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.